Scientists have developed a nanoparticle strategy to broaden which disease-causing proteins medicines can target, giving options for dementia and brain cancer. A perspective outlines an approach...
Exciva has raised US$59.4m in series B funding to support a phase 2 trial of its Alzheimer’s therapy. The clinical-stage biopharmaceutical company is developing treatments for...
SciNeuro Pharmaceuticals has entered a worldwide licensing and collaboration agreement with Novartis to advance its amyloid beta-targeted antibody programme for Alzheimer’s disease. The programme has identified...
L-Nutra has raised US$36.5m in series D funding for what it describes as science-driven nutrition for longevity and nutrition as medicine. The round brings its series...
Shingles vaccination may slow biological ageing in older adults, research suggests. The study examined more than 3,800 people aged 70 and older and found that those...
Thousands of men in England will get the prostate cancer drug abiraterone on the NHS within weeks. For the first time, patients in England whose cancer...
Sharp rises in blood sugar after meals may raise Alzheimer’s risk, according to genetic analysis of more than 350,000 adults. The findings point to after-meal glucose,...
